Understanding the Rh Factor: Clinical Significance and Pregnancy Management

Medically reviewed by Dr. Baraa Alnahhal, MD · Last reviewed: October 2026

The Rh factor is a protein found on the surface of red blood cells that determines whether a blood type is positive or negative. While it does not affect general health, Rh status is critical during pregnancy, as incompatibility between an Rh-negative parent and an Rh-positive fetus can lead to Rh sensitization. This immune response can cause hemolytic anemia in subsequent pregnancies, but it is highly preventable through timely Rh immune globulin (RhoGAM) injections. [1]

Quick Answer: What is the Rh factor?

The Rh factor, or Rhesus factor, is an inherited protein on the surface of red blood cells; people with it are Rh-positive and those without it are Rh-negative. Approximately 85% of people are Rh-positive. [1] It matters most in pregnancy, when an Rh-negative person carrying an Rh-positive fetus may develop an immune response, which is managed with specialized injections. [1]

What the research says

• Anti-D prophylaxis is given at 28 weeks, and either injection route is used. A Cochrane review of 2 trials (447 RhD-negative women given 1500 IU of anti-D at week 28) found no RhD alloimmunization with either intramuscular or intravenous administration, although the number of events was too small to compare the two routes meaningfully (Okwundu et al., Cochrane Database of Systematic Reviews, 2013) [2].

• Body weight may influence anti-D levels. A meta-analysis found a significant negative correlation between high BMI or body weight and serial anti-D levels in RhD-negative pregnant women carrying RhD-positive fetuses (r = -0.59; 95% CI -0.83 to -0.35), though the authors urged caution because of study limitations (Ngan et al., Vox Sanguinis, 2024) [3].

Defining the Rh Factor and Inheritance

The Rh factor is a specific type of protein found on the surface of red blood cells. [1] As a genetic trait, Rh status is inherited from biological parents, and the presence or absence of this protein defines the "positive" or "negative" designation attached to common blood types such as A, B, and O. For the vast majority of people, their Rh status has no bearing on their overall health or daily well-being. [1] It remains a dormant biological marker until blood from different Rh statuses is mixed, which most commonly occurs during medical procedures or pregnancy.

Understanding the distribution of Rh factors within the population helps healthcare providers anticipate potential compatibility issues. The following table outlines the most common blood type classifications and their associated Rh designations.

Blood Type	Rh Factor Status	Clinical Designation
A	Protein Present	A Positive (A+)
A	Protein Absent	A Negative (A-)
B	Protein Present	B Positive (B+)
B	Protein Absent	B Negative (B-)
O	Protein Present	O Positive (O+)
O	Protein Absent	O Negative (O-)

Mechanics of Rh Incompatibility

Rh incompatibility arises specifically when a biological parent who is Rh-negative becomes pregnant with a fetus that has inherited Rh-positive blood from the other biological parent. In these instances, the parent's immune system may recognize the fetal Rh protein as a foreign substance. This recognition triggers the production of antibodies designed to attack the fetal red blood cells, a process known as Rh sensitization. [1] While the parent and fetus do not typically share blood during gestation, mixing can occur during labor, delivery, or specific clinical events. [1]

Triggers for Blood Mixing

Several events during pregnancy can facilitate the mixing of fetal and parental blood, leading to potential sensitization. Healthcare providers monitor these situations closely to determine if preventive treatment is necessary.

• Labor and Delivery: The most common time for blood mixing is during vaginal or cesarean delivery. [1] [2]

• Prenatal Diagnostics: Procedures such as amniocentesis or chorionic villus sampling (CVS) can inadvertently cause blood to mix. [1]

• Physical Trauma: Injury or significant trauma to the abdomen during pregnancy increases the risk of fetal-maternal hemorrhage. [1]

• Pregnancy Complications: Vaginal bleeding, miscarriage, or ectopic pregnancy are known triggers for Rh sensitization. [1]

Risks to Fetal Health and Rh Disease

The primary risk of Rh incompatibility is rarely seen during a first pregnancy, as sensitization usually occurs at the time of delivery, meaning antibodies do not form until after the first child is born. [1] [2] However, if a sensitized individual becomes pregnant again with another Rh-positive fetus, the existing antibodies can cross the placenta. These antibodies then target and destroy the fetus's red blood cells faster than the fetus can replace them, a condition known as Rh disease or hemolytic anemia. [1]

The severity of Rh disease can vary significantly, ranging from mild cases requiring no intervention to life-threatening complications. The following table summarizes the potential effects of Rh disease on a developing fetus.

Severity Level	Potential Fetal Complications	Typical Management
Mild	Mild anemia, slight jaundice	Monitoring, often no active treatment
Moderate	Significant jaundice, liver stress	Phototherapy (special lights) after birth
Severe	Heart failure, liver failure, stillbirth	Fetal blood transfusion, early delivery [1]

Diagnosis and Clinical Testing

Every pregnant individual undergoes an Rh factor test during their first trimester, typically at the initial prenatal appointment. This "type and screen" blood test identifies the parent's Rh status and checks for the presence of existing antibodies. [1] If the parent is Rh-positive, no further action regarding Rh incompatibility is required. If the parent is Rh-negative, the medical team will implement a preventive care plan to protect the current and future pregnancies.

Management and Preventive Treatment

The development of Rh immune globulin (RhIg), commonly known by the brand name RhoGAM®, has made Rh disease a rare occurrence in modern medicine. [1] This medication works by preventing the Rh-negative parent's immune system from reacting to Rh-positive blood, effectively stopping the formation of antibodies. [1] It is important to note that RhIg is only effective if the body has not yet begun producing its own antibodies. [1]

Standard Treatment Timeline

For Rh-negative individuals, the administration of RhIg follows a specific clinical schedule to ensure continuous protection.

• 28 Weeks Gestation: A standard dose is administered to prevent sensitization during the third trimester. [1] [2]

• Post-Delivery: A second dose is given within 72 hours of birth if the newborn is confirmed to be Rh-positive. [1] [2]

• Suspected Mixing Events: Supplemental doses may be administered following abdominal trauma, vaginal bleeding, or invasive prenatal testing. [1]

Conclusion and Next Steps

The Rh factor is a vital biological marker that requires careful management during pregnancy to ensure the safety of the fetus. While Rh incompatibility can lead to serious complications like Rh disease, modern preventive treatments have rendered these outcomes infrequent. By identifying Rh status early through routine prenatal screening and adhering to the recommended injection schedule, Rh-negative individuals can expect healthy pregnancy outcomes. If you are planning a pregnancy or are currently pregnant, ensure your healthcare provider has confirmed your Rh status and discussed any necessary preventive measures.

---

Frequently Asked Questions

What is the most common Rh factor?

Approximately 85% of the global population is Rh-positive, meaning they possess the Rh protein on their red blood cells.

Can Rh incompatibility affect the pregnant parent's health?

No, Rh incompatibility does not affect the health or well-being of the pregnant individual; it only poses a risk to the health of the fetus.

What happens if I already have Rh antibodies?

If sensitization has already occurred, RhIg injections will not be effective. In these cases, the pregnancy is closely monitored for signs of fetal anemia, and specialized treatments like fetal transfusions may be used.

Is Rh factor protein genetic?

Yes, the Rh factor is inherited from your biological parents. It is not possible to choose or change your Rh status.

How often do I need RhoGAM shots?

RhIg injections are required during every pregnancy where Rh incompatibility is a risk, typically at 28 weeks and again after delivery.

Can a father's Rh factor cause problems?

Incompatibility only occurs if the pregnant parent is Rh-negative and the other biological parent is Rh-positive, potentially resulting in an Rh-positive fetus.

What is Rh sensitization?

Rh sensitization is the process where an Rh-negative person's immune system produces antibodies after being exposed to Rh-positive blood.

Are there side effects to the RhIg injection?

RhIg injections are highly successful and standard in prenatal care, though individuals should discuss specific concerns with their provider.

Can Rh disease be treated after birth?

Yes, newborns with Rh disease may receive phototherapy for jaundice or blood transfusions to replace damaged red blood cells.

Does a first baby ever get Rh disease?

It is extremely rare for a first baby to be affected because the parent's body usually doesn't produce enough antibodies until after the first delivery.

---

Related Reading

Cordocentesis (PUBS): Umbilical Cord Blood Test, Risks and Results explains the umbilical cord blood test used when other prenatal tests are unclear.

Coombs Test: Direct vs Indirect, Why It's Done and What Results Mean explains the blood test that finds antibodies attacking red blood cells.

Learn more in our guide to Nonstress Test (NST): Why It's Done, What to Expect and Reactive vs Nonreactive Results.

References

1. Cleveland Clinic. Rh Factor. Cleveland Clinic. Last updated November 10, 2022. https://my.clevelandclinic.org/health/diseases/21053-rh-factor

2. Okwundu CI, Afolabi BB. Intramuscular versus intravenous anti-D for preventing Rhesus alloimmunization during pregnancy. Cochrane Database of Systematic Reviews. 2013;(1):CD007885. PMID 23440818. https://doi.org/10.1002/14651858.CD007885.pub2

3. Ngan CBM, Kaur R, Jackson DE. Does high body mass index (>25 kg/m2) or weight (>80 kg) reduce the effectiveness of anti-D prophylaxis in Rh(D)-negative pregnant women? A systematic review and meta-analysis. Vox Sanguinis. 2024;119(9):902-911. PMID 38889996. https://doi.org/10.1111/vox.13693

Medical disclaimer

The information provided in this article is for educational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.